Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty

Cytokine

Volumn 46, Issue 3, 2009, Pages 319-324

  Qu, Tao ^a   Yang, Huanle ^a   Walston, Jeremy D ^a   Fedarko, Neal S ^a   Leng, Sean X ^a  

^a Division of Geriatric Medicine and Gerontology   (United States)

Author keywords

CXCL 10; Frailty; IL 6; Inflammation; Monocytic gene expression

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; DISABILITY; FEMALE; FRAIL ELDERLY; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; MALE; MOLECULAR MECHANICS; MONOCYTE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CXCL10; FEMALE; FRAIL ELDERLY; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-6; MICROARRAY ANALYSIS; MONOCYTES; SYNDROME; UP-REGULATION;

EID: 67349178333     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.02.015     Document Type: Article

References (34)

1. Fried L.P., Tangen C., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56A 3 (2001) M1-M11
2. Fried L.P., and Frailty W.J. In: Halter J.B. (Ed). Hazzard's principles of geriatric medicine and gerontology (2007), McGraw-Hill, Anne Arbor
3. Fried L.P., Hadley E.C., Walston J.D., et al. From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ 2005 31 (2005) e24
4. Fried L.P., Ferrucci L., Darer J., Williamson J.D., and Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59 3 (2004) 255-263
5. Leng S., Chaves P., Koenig K., and Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50 7 (2002) 1268-1271
6. Schmaltz H.N., Fried L.P., Xue Q.L., Walston J., Leng S.X., and Semba R.D. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 53 5 (2005) 747-754
7. Walston J., McBurnie M.A., Newman A., et al. Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: results from the Cardiovascular Health Study. Arch Intern Med 162 (2002) 2333-2341
8. Leng S.X., Xue Q.L., Tian J., Walston J.D., and Fried L.P. Inflammation and frailty in older women. J Am Geriatr Soc 55 6 (2007) 864-871
9. De M.M., Franceschi C., Monti D., and Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80 3 (2006) 219-227
10. Maggio M., Guralnik J.M., Longo D.L., and Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61 6 (2006) 575-584
11. Leng S.X., Cappola A.R., Andersen R.E., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16 2 (2004) 153-157
12. Chaves P.H., Semba R.D., Leng S.X., et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 60 6 (2005) 729-735
13. Ferrucci L., Penninx B.W., Volpato S., et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50 12 (2002) 1947-1954
14. Paganelli R., Di I.A., Cherubini A., et al. Frailty of older age: the role of the endocrine-immune interaction. Curr Pharm Des 12 24 (2006) 3147-3159
15. Neville L.F., Mathiak G., and Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8 3 (1997) 207-219
16. Miles E.A., Rees D., Banerjee T., et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis 196 1 (2008) 298-305
17. Antonelli A., Rotondi M., Fallahi P., et al. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 34 1-2 (2006) 32-38
18. Antonelli A., Rotondi M., Fallahi P., et al. Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. J Interferon Cytokine Res 25 9 (2005) 547-552
19. Shurin G.V., Yurkovetsky Z.R., Chatta G.S., Tourkova I.L., Shurin M.R., and Lokshin A.E. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 39 2 (2007) 123-129
20. Franciotta D., Martino G., Zardini E., et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 115 1-2 (2001) 192-198
21. Antonelli A., Rotondi M., Fallahi P., et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89 11 (2004) 5496-5499
22. + monocytes in frail older adults. Mech Ageing Dev 130 (2009) 161-166
23. De M.M., Modesti M., and Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from elderly persons. Immunol Cell Biol 82 4 (2004) 415-420
24. Sadeghi H.M., Schnelle J.F., Thoma J.K., Nishanian P., and Fahey J.L. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 34 8 (1999) 959-970
25. Comabella M., Imitola J., Weiner H.L., and Khoury S.J. Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients. J Neuroimmunol 126 1-2 (2002) 205-212
26. Nicoletti F., Conget I., Di M.M., et al. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45 8 (2002) 1107-1110
27. Rotondi M., Rosati A., Buonamano A., et al. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 4 9 (2004) 1466-1474
28. De F.U., Wang G.C., Fedarko N.S., Walston J.D., Casolaro V., and Leng S.X. T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc 56 5 (2008) 904-908
29. Matsusaka T., Fujikawa K., Nishio Y., et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90 21 (1993) 10193-10197
30. Lazzeri E., and Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 5 1 (2005) 109-118
31. Romagnani P. From basic science to clinical practice. use of cytokines and chemokines as therapeutic targets in renal diseases. J Nephrol 18 3 (2005) 229-233
32. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166 12 (2001) 7617-7624
33. Wojcik W.J., Swoveland P., Zhang X., and Vanguri P. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat. J Pharmacol Exp Ther 278 1 (1996) 404-410
34. Wildbaum G., Netzer N., and Karin N. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J Immunol 168 11 (2002) 5885-5892